Krebs Biochemicals & Industries Soars to 52-Week High, Outperforming Sector and Sensex

Jul 19 2024 09:35 AM IST
share
Share Via
Krebs Biochemicals & Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on July 19, 2024. The company's consistent growth and positive market sentiment have contributed to this success, with the stock outperforming the sector and the Sensex. While there is some volatility, the company's strong performance and potential for growth make it a promising player in the pharmaceutical industry.


Krebs Biochemicals & Industries, a microcap pharmaceutical company, has been making headlines in the stock market as its stock price reached a 52-week high on July 19, 2024. The stock has been on an upward trend for the past 6 days, gaining an impressive 46.98% in returns during this period. Today, the stock opened with a gain of 5.7% and touched an intraday high of Rs 120.87, outperforming the sector by 14.26%.

The company's strong performance can be attributed to its consistent growth and positive market sentiment. Krebs Biochemicals & Industries is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend in the market.

In the past year, Krebs Biochemicals & Industries has outperformed the Sensex by an impressive 67.09%, while the Sensex has only seen a 21.09% growth. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.

While the stock has been highly volatile today, with an intraday volatility of 8.74%, it has been able to maintain its upward trend. However, it is important to note that MarketsMOJO has given a 'Sell' call for the stock, indicating a cautious approach for investors.

Overall, Krebs Biochemicals & Industries has shown promising growth and performance in the past year, making it a company to watch out for in the microcap pharmaceutical industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
Dec 25 2025 12:57 PM IST
share
Share Via
Why is Krebs Biochem falling/rising?
Dec 13 2025 01:05 AM IST
share
Share Via
Why is Krebs Biochem falling/rising?
Nov 12 2025 10:09 PM IST
share
Share Via
How has been the historical performance of Krebs Biochem?
Nov 04 2025 10:51 PM IST
share
Share Via
Are Krebs Biochem latest results good or bad?
Nov 04 2025 07:45 PM IST
share
Share Via